Effectiveness of immunosuppressive treatment for recurrent or refractory pancreas allograft rejection: correlation with histologic grade.
Papadimitriou
J C
JC
Department of Pathology, University of Maryland School of Medicine, Baltimore, USA.
Wiland
A
A
Drachenberg
C B
CB
Klassen
D K
DK
Bartlett
S T
ST
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D011241:Prednisone